{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:15:23Z","timestamp":1788405323135,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Older adults undergoing systemic anti-cancer therapy (SACT) with steroids are at high risk of developing steroid-induced hyperglycaemia (SIH). However, monitoring and management remain inconsistent. This quality improvement project (QIP) involved developing and evaluating the GOLD diabetes enhanced monitoring pathway, a multidisciplinary, age-adapted initiative for older patients at intermediate SIH risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The pathway was implemented at Guy\u2019s and St Thomas\u2019 NHS Foundation Trust between February 2022 and June 2025. This included collaborative planning, structured risk stratification, diabetes education, home capillary blood glucose monitoring, telephone follow-up by geriatric clinical nurse specialists, medication and safety protocols. Iterative refinements were made through seven Plan-Do-Study-Act (PDSA) cycles. The primary outcome was the rate of SIH requiring diabetes medication intervention, whilst secondary outcomes included changes in SACT\/steroid regimens, unplanned hospitalisations, and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 126 patients (58% male; median age 74\u00a0years [IQR: 70\u201379]; 77% with pre-existing diabetes), diabetes medication intervention was provided in 32%, primarily with the initiation or escalation of gliclazide. Only three asymptomatic hypoglycaemic events occurred. Unplanned hospitalisations occurred in 28% of patients (\n                      <jats:italic>n\u2009=\u2009<\/jats:italic>\n                      35), with only two admissions related to diabetes. All-cause mortality (33%,\n                      <jats:italic>n\u2009=\u2009<\/jats:italic>\n                      41) was associated with metastatic disease, malnutrition, and social isolation, but not with glycaemic control or diabetes intervention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The GOLD pathway appears feasible, safe, and effective in managing SIH in older adults with cancer. Its success highlights the value of multidisciplinary collaboration and iterative refinement in addressing a critical gap in geriatric oncology care, as well as supporting structured diabetes monitoring in clinical practice. Larger multi-centre implementation effectiveness evaluation will enable sustainable, cost-effective practice across diverse settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-026-01585-w","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:45:26Z","timestamp":1788403526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving diabetes management in older adults with cancer: a quality improvement project to enhance monitoring during steroid-based systemic anti-cancer therapy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-5064","authenticated-orcid":false,"given":"Evelyne","family":"Liuu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Bassas-Letissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitanjali","family":"Amaratunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Compton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Kalsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk-Fun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Nottage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah L.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"issue":"5","key":"1585_CR1","first-page":"405","volume":"74","author":"F Islami","year":"2019","unstructured":"Islami F, Marlow EC, Thomson B et al (2019) Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019. CA Cancer J Clin 74(5):405\u2013432","journal-title":"CA Cancer J Clin"},{"issue":"9836","key":"1585_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M et al (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380(9836):37\u201343","journal-title":"Lancet"},{"key":"1585_CR3","doi-asserted-by":"publisher","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS et al (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607","journal-title":"BMJ"},{"issue":"9","key":"1585_CR4","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.2337\/dc20-0204","volume":"43","author":"S Ling","year":"2020","unstructured":"Ling S, Brown K, Miksza JK et al (2020) Association of type 2 diabetes with cancer: a meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people. Diabetes Care 43(9):2313\u20132322","journal-title":"Diabetes Care"},{"key":"1585_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.metabol.2017.09.013","volume":"78","author":"M Gallo","year":"2018","unstructured":"Gallo M, Muscogiuri G, Felicetti F et al (2018) Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes. Metabolism 78:141\u2013154","journal-title":"Metabolism"},{"issue":"6","key":"1585_CR6","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/ageing\/afab157","volume":"50","author":"A Christiaens","year":"2021","unstructured":"Christiaens A, Henrard S, Zerah L et al (2021) Individualisation of glycaemic management in older people with type 2 diabetes: a systematic review of clinical practice guidelines recommendations. Age Ageing 50(6):1935\u20131942","journal-title":"Age Ageing"},{"issue":"4","key":"1585_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.clon.2018.01.003","volume":"30","author":"R Barua","year":"2018","unstructured":"Barua R, Templeton AJ, Seruga B et al (2018) Hyperglycaemia and survival in solid tumours: a systematic review and meta-analysis. Clin Oncol (R Coll Radiol) 30(4):215\u2013224","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1585_CR8","doi-asserted-by":"crossref","unstructured":"Rao Kondapally Seshasai S, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829\u201141.","DOI":"10.1056\/NEJMoa1008862"},{"issue":"5","key":"1585_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4093\/dmj.2014.38.5.330","volume":"38","author":"TY Ryu","year":"2014","unstructured":"Ryu TY, Park J, Scherer PE (2014) Hyperglycemia as a risk factor for cancer progression. Diabetes Metab J 38(5):330\u2013336","journal-title":"Diabetes Metab J"},{"issue":"6","key":"1585_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102062","volume":"8","author":"N Silvestris","year":"2023","unstructured":"Silvestris N, Franchina T, Gallo M et al (2023) Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper. ESMO Open 8(6):102062","journal-title":"ESMO Open"},{"issue":"4","key":"1585_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jdiacomp.2018.12.012","volume":"33","author":"D Zylla","year":"2019","unstructured":"Zylla D, Gilmore G, Eklund J et al (2019) Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy. J Diabetes Complications 33(4):335\u2013339","journal-title":"J Diabetes Complications"},{"key":"1585_CR12","doi-asserted-by":"crossref","unstructured":"Joharatnam-Hogan N, Chambers P, Dhatariya K, Board R, Joint British Diabetes Society for Inpatient Care (JBDS), UK Chemotherapy Board (UKCB). A guideline for the outpatient management of glycaemic control in people with cancer. Diabet Med J Br Diabet Assoc. 2022;39(1):e14636.","DOI":"10.1111\/dme.14636"},{"issue":"3","key":"1585_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s12032-013-0687-4","volume":"30","author":"G Ji","year":"2013","unstructured":"Ji G, Jin L, Wang R et al (2013) Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment. Med Oncol Northwood Lond Engl 30(3):687","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"8","key":"1585_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/dci24-0032","volume":"47","author":"GE Umpierrez","year":"2024","unstructured":"Umpierrez GE, Davis GM, ElSayed NA et al (2024) Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care 47(8):1257\u20131275","journal-title":"Diabetes Care"},{"issue":"2","key":"1585_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2337\/dci19-0066","volume":"43","author":"JB Buse","year":"2019","unstructured":"Buse JB, Wexler DJ, Tsapas A et al (2019) 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43(2):487\u2013493","journal-title":"Diabetes Care"},{"issue":"9","key":"1585_CR16","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s40520-019-01362-9","volume":"32","author":"E Liuu","year":"2020","unstructured":"Liuu E, Saulnier PJ, Gand E et al (2020) Frailty and diabetes status in older patients with cancer: impact on mortality in the ANCRAGE cohort. Aging Clin Exp Res 32(9):1809\u20131819","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"1585_CR17","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/bjc.2015.120","volume":"112","author":"T Kalsi","year":"2015","unstructured":"Kalsi T, Babic-Illman G, Ross PJ et al (2015) The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people. Br J Cancer 112(9):1435\u20131444","journal-title":"Br J Cancer"},{"issue":"12","key":"1585_CR18","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","volume":"25","author":"G Ogrinc","year":"2016","unstructured":"Ogrinc G, Davies L, Goodman D et al (2016) SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. BMJ Qual Saf 25(12):986\u2013992","journal-title":"BMJ Qual Saf"},{"issue":"5","key":"1585_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2024.102077","volume":"16","author":"R Bartsch","year":"2025","unstructured":"Bartsch R, Aletaha D, Fuereder T et al (2025) Corticosteroid therapy in older adults with cancer: expert recommendations from a task force of the International Society of Geriatric Oncology. J Geriatr Oncol 16(5):102077","journal-title":"J Geriatr Oncol"},{"issue":"Suppl 1","key":"1585_CR20","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.2337\/dc23-S009","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR et al (2023) 9. Pharmacologic approaches to glycemic treatment: standards of care in Diabetes-2023. Diabetes Care 46(Suppl 1):S140\u2013S157","journal-title":"Diabetes Care"},{"key":"1585_CR21","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S55\u201164.","DOI":"10.2337\/dc18-S006"},{"issue":"3","key":"1585_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","volume":"1","author":"PA Hart","year":"2016","unstructured":"Hart PA, Bellin MD, Andersen DK et al (2016) Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1(3):226\u2013237","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1585_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12913-019-4482-6","volume":"19","author":"SV Knudsen","year":"2019","unstructured":"Knudsen SV, Laursen HVB, Johnsen SP et al (2019) Can quality improvement improve the quality of care? A systematic review of reported effects and methodological rigor in plan-do-study-act projects. BMC Health Serv Res 19(1):683","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1585_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","volume":"55","author":"M Extermann","year":"2005","unstructured":"Extermann M, Aapro M, Bernabei R et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55(3):241\u2013252","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"1585_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ Can Med Assoc J Assoc Medicale Can 173(5):489\u2013495","journal-title":"CMAJ Can Med Assoc J Assoc Medicale Can"},{"key":"1585_CR26","doi-asserted-by":"publisher","DOI":"10.1200\/GO-25-00276","volume":"11","author":"CD Bergerot","year":"2025","unstructured":"Bergerot CD, Temin S, Verduzco-Aguirre HC et al (2025) Geriatric Assessment: ASCO Global Guideline. JCO Glob Oncol 11:e2500276","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"1585_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2021.101289","volume":"48","author":"E Liuu","year":"2022","unstructured":"Liuu E, Saulnier PJ, Gand E et al (2022) Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach. Diabetes Metab 48(2):101289","journal-title":"Diabetes Metab"},{"key":"1585_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1114","volume":"365","author":"E Karslioglu French","year":"2019","unstructured":"Karslioglu French E, Donihi AC, Korytkowski MT (2019) Diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome: review of acute decompensated diabetes in adult patients. BMJ 365:l1114","journal-title":"BMJ"},{"issue":"4","key":"1585_CR29","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/ageing\/afz021","volume":"48","author":"G Ellis","year":"2019","unstructured":"Ellis G, Sevdalis N (2019) Understanding and improving multidisciplinary team working in geriatric medicine. Age Ageing 48(4):498\u2013505","journal-title":"Age Ageing"},{"issue":"4","key":"1585_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jdi.13204","volume":"11","author":"H Noto","year":"2020","unstructured":"Noto H (2020) Dawn of a new era of diabeto-oncology. J Diabetes Investig 11(4):755\u2013756","journal-title":"J Diabetes Investig"},{"issue":"5","key":"1585_CR31","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/1932296815590827","volume":"9","author":"ME Mabrey","year":"2015","unstructured":"Mabrey ME, Setji TL (2015) Patient self-management of diabetes care in the inpatient setting: pro. J Diabetes Sci Technol 9(5):1152\u20131154","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"1585_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s41999-025-01354-1","volume":"17","author":"M S\u00e4\u00e4skilahti","year":"2026","unstructured":"S\u00e4\u00e4skilahti M, Aarnio E, Lev\u00e4lahti E et al (2026) Cardiovascular and glucose-lowering medication use among older adults: results from 9-year follow-up of the FINGER trial. Eur Geriatr Med 17(2):961\u2013973. https:\/\/doi.org\/10.1007\/s41999-025-01354-1","journal-title":"Eur Geriatr Med"},{"issue":"22","key":"1585_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225735","volume":"13","author":"RK Shahid","year":"2021","unstructured":"Shahid RK, Ahmed S, Le D, Yadav S (2021) Diabetes and cancer: risk, challenges, management and outcomes. Cancers (Basel) 13(22):5735","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1585_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jcjd.2022.11.007","volume":"47","author":"SM Ruzycki","year":"2023","unstructured":"Ruzycki SM, Kuzma T, Harrison TG et al (2023) Implementation of a perioperative glycemic management quality improvement pathway in gynecologic oncology patients: a single-cohort interrupted time-series analysis. Can J Diabetes 47(3):228-235.e5","journal-title":"Can J Diabetes"},{"issue":"7","key":"1585_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/dme.13919","volume":"36","author":"TA Chowdhury","year":"2019","unstructured":"Chowdhury TA, Jacob P (2019) Challenges in the management of people with diabetes and cancer. Diabet Med J Br Diabet Assoc 36(7):795\u2013802","journal-title":"Diabet Med J Br Diabet Assoc"},{"issue":"9","key":"1585_CR36","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/S2666-7568(22)00169-6","volume":"3","author":"WK Soo","year":"2022","unstructured":"Soo WK, King MT, Pope A, Parente P, D\u0101rzi\u0146\u0161 P, Davis ID (2022) Integrated geriatric assessment and treatment effectiveness (integerate) in older people with cancer starting systemic anticancer treatment in australia: a multicentre, open-label, randomised controlled trial. Lancet Healthy Longev 3(9):e617\u2013e627","journal-title":"Lancet Healthy Longev"},{"issue":"10314","key":"1585_CR37","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H et al (2021) Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet 398(10314):1894\u20131904","journal-title":"Lancet"},{"issue":"11","key":"1585_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.4158","volume":"7","author":"D Li","year":"2021","unstructured":"Li D, Sun CL, Kim H et al (2021) Geriatric assessment-driven intervention (gain) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol 7(11):e214158","journal-title":"JAMA Oncol"},{"issue":"19","key":"1585_CR39","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1200\/JCO.21.00118","volume":"39","author":"AE Chapman","year":"2021","unstructured":"Chapman AE, Elias R, Plotkin E et al (2021) models of care in geriatric oncology. J Clin Oncol 39(19):2195\u20132204","journal-title":"J Clin Oncol"},{"issue":"1","key":"1585_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-025-03161-x","volume":"37","author":"E Liuu","year":"2025","unstructured":"Liuu E, Battisti NML, Galvin A et al (2025) Remote monitoring in older adults with cancer, opportunities and challenges: a narrative review. Aging Clin Exp Res 37(1):249","journal-title":"Aging Clin Exp Res"},{"issue":"6","key":"1585_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/qjmed\/hcu218","volume":"108","author":"P Jacob","year":"2015","unstructured":"Jacob P, Chowdhury TA (2015) Management of diabetes in patients with cancer. QJM Mon J Assoc Physicians 108(6):443\u2013448","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"18","key":"1585_CR42","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.3390\/cancers15184544","volume":"15","author":"J Paris","year":"2023","unstructured":"Paris J, Legris P, Devaux M et al (2023) Impact of a tripartite collaboration between oncologist, pharmacist and diabetologist in the management of patients with diabetes starting chemotherapy: the oncodiab trial. Cancers 15(18):4544","journal-title":"Cancers"},{"issue":"4","key":"1585_CR43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.numecd.2022.01.027","volume":"32","author":"E Mannucci","year":"2022","unstructured":"Mannucci E, Candido R, Delle Monache L et al (2022) Italian guidelines for the treatment of type 2 diabetes. Nutr Metab Cardiovasc Dis NMCD 32(4):770\u2013814","journal-title":"Nutr Metab Cardiovasc Dis NMCD"},{"issue":"19","key":"1585_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194782","volume":"15","author":"EG Khoury","year":"2023","unstructured":"Khoury EG, Nuamek T, Heritage S et al (2023) Geriatric oncology as an unmet workforce training need in the United Kingdom-A narrative review by the British Oncology Network for Undergraduate Societies (BONUS) and the International Society of Geriatric Oncology (SIOG) UK Country Group. Cancers 15(19):4782","journal-title":"Cancers"},{"issue":"1","key":"1585_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-026-07333-w","volume":"26","author":"N Bassas Letissier","year":"2026","unstructured":"Bassas Letissier N, Mosbah H, Saulnier PJ et al (2026) Feasibility of continuous glucose monitoring in an acute geriatric unit - the GLYCOGER study. BMC Geriatr 26(1):578. https:\/\/doi.org\/10.1186\/s12877-026-07333-w","journal-title":"BMC Geriatr"},{"issue":"1","key":"1585_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s43058-021-00137-6","volume":"2","author":"C Laur","year":"2021","unstructured":"Laur C, Corrado AM, Grimshaw JM, Ivers N (2021) Trialists perspectives on sustaining, spreading, and scaling-up of quality improvement interventions. Implement Sci Commun 2(1):35","journal-title":"Implement Sci Commun"},{"issue":"7","key":"1585_CR47","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.2337\/dci20-0017","volume":"43","author":"KR Siegel","year":"2008","unstructured":"Siegel KR, Ali MK, Zhou X et al (2008) Cost-effectiveness of interventions to manage diabetes: has the evidence changed since 2008? Diabetes Care 43(7):1557\u20131592","journal-title":"Diabetes Care"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-026-01585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-026-01585-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-026-01585-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:45:28Z","timestamp":1788403528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-026-01585-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":47,"alternative-id":["1585"],"URL":"https:\/\/doi.org\/10.1007\/s41999-026-01585-w","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This QIP was registered and approved by the Guy\u2019s and St Thomas\u2019 NHS Foundation Trust audit and service evaluation governance team (project number: 18 525). The analysis of anonymised data generated during this QIP was conducted in line with local information governance processes and guidance set out by the Health Research Authority, further ethical approvals were not required. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}